Načítá se...
COMP-05. A DRUG ASSOCIATION MAP OF GLIOBLASTOMA INFORMS PRECISION TARGETING OF p53-DEPENDENT METABOLIC STATES
Glioblastoma (GBM) is a malignant brain tumor with few therapeutic options. Because GBMs are genetically and functionally diverse, there is little systematic understanding of how hundreds of approved drugs may be active against GBM subpopulations. To identify new pharmacological subgroups of GBM, we...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6846896/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.248 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|